Biosergen AB's market cap is currently €11.22M. The company's EPS TTM is €-0.004274979; its P/E ratio is ―; Biosergen AB is scheduled to report earnings on August 20, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
